PUBLIC DISCLOSURE & CLARIFICATION
BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
banner
Antibody Engineering
  • Home
    • Antibody Engineering

Antibody Engineering

July 3, 2026
Antibody–Lectin Chimeras Turn Tumor Sugars into Immune Targets

Checkpoint blockade has reshaped cancer care, yet a large fraction of patients never respond to the antibodies now in the clinic. One underappreciated reason is that tumors wrap themselves in sugar coatings that quietly tell immune cells to stand down. A new study reframes these sugars as druggable switches rather than passive decorations. Glycomics has […]

Read More >
Categories
Recent Posts
From Protein-Rich to Protein-Free: CryoSeek Uncovers a Structural Continuum of GlycofibrilsFrom Protein-Rich to Protein-Free: CryoSeek Uncovers a Structural Continuum of Glycofibrils
The Mouse <em>N</em>-Glycoproteome Atlas: Tissue-Specific Glycan Signatures DecodedThe Mouse N-Glycoproteome Atlas: Tissue-Specific Glycan Signatures Decoded
Benchmarking Glycan Profiles of 209 FDA-Approved AntibodiesBenchmarking Glycan Profiles of 209 FDA-Approved Antibodies
IM-MS Self-Expanding Database Unlocks Glycan Isomer IdentificationIM-MS Self-Expanding Database Unlocks Glycan Isomer Identification

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Important Links

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.